Douglas L. Rosene
- Cognitive Neuroscience top 0.2%
- Cellular and Molecular Neuroscience top 0.2%
- Neurology top 0.2%
- Molecular Biology top 5%
- Physiology top 1%
- Co-authors
- Gary W. Van HoesenMark B. MossDeepak Ν. PandyaM.‐Marsel MesulamRonald KillianyBrent A. VogtGene J. BlattAlan Peters
- Topics
- Neuroscience and Neuropharmacology Research (48 papers)Memory and Neural Mechanisms (47 papers)Neuroinflammation and Neurodegeneration Mechanisms (31 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Douglas L. Rosene
191 papers receiving 10.7k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Cognitive Neuroscience 4.9k
- Cellular and Molecular Neuroscience 3.8k
- Neurology 2.0k
- Molecular Biology 1.8k
- Physiology 1.6k
Countries citing papers authored by Douglas L. Rosene
This map shows the geographic impact of Douglas L. Rosene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas L. Rosene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas L. Rosene more than expected).
Fields of papers citing papers by Douglas L. Rosene
This network shows the impact of papers produced by Douglas L. Rosene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas L. Rosene. The network helps show where Douglas L. Rosene may publish in the future.
Co-authorship network of co-authors of Douglas L. Rosene
This figure shows the co-authorship network connecting the top 25 collaborators of Douglas L. Rosene. A scholar is included among the top collaborators of Douglas L. Rosene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas L. Rosene. Douglas L. Rosene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 16 | |
| 4 | 15 | |
| 5 | 2 | |
| 6 | 6 | |
| 7 | 93 | |
| 8 | 101 | |
| 9 | 13 | |
| 10 | 3 | |
| 11 | 315 | |
| 12 | 42 | |
| 13 | 25 | |
| 14 | 100 | |
| 15 | 4 | |
| 16 | 11 | |
| 17 | 83 | |
| 18 | 31 | |
| 19 | 142 | |
| 20 | 72 |
About Douglas L. Rosene
Douglas L. Rosene is a scholar working on Developmental Neuroscience, Neurology and Cognitive Neuroscience, having authored 191 papers that have together received 10.9k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (48 papers), Memory and Neural Mechanisms (47 papers) and Neuroinflammation and Neurodegeneration Mechanisms (31 papers). The work is most often cited by research in Developmental Neuroscience (1.2k citations), Cognitive Neuroscience (4.9k citations) and Neurology (2.0k citations). Douglas L. Rosene has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Gary W. Van Hoesen, Mark B. Moss, Deepak Ν. Pandya, M.‐Marsel Mesulam, Ronald Killiany, Brent A. Vogt, Gene J. Blatt, Alan Peters, Tara L. Moore and James G. Herndon. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.